Zydus Lifesciences Limited has informed the Exchange about press release dated 17-Oct-2022 titled 1. Zydus receives tentative approval from the USFDA for Valbenazine Capsules and 2. Zydus receives tentative approval from the USFDA for Roflumilast Tablets